Ads
related to: pancreatic cancer chemotherapy- Dosing & Administration
Find Important Dosing, Modification
& Administration Info for Providers
- Read The Patient Brochure
Help Patients Take An Active Role
During Treatment. Download & Share.
- Resources For Oncologists
Download Dosing Guide, Watch Videos
and More for Providers
- Clinical Efficacy, Safety
See Efficacy Results & Study Info
for This Treatment Option
- Prescribing Information
Provider Info for a Metastatic
Pancreatic Cancer Treatment Option
- Contact a Specialist
HCPs: Get In Touch with an Oncology
Account Specialist for More Info
- Dosing & Administration
Search results
Pancreatic cancer: Some signs that cancer has spread
Medical News Today· 6 days agoWhen pancreatic cancer spreads to other areas of the body, a person may experience new symptoms that are not directly linked to the tumors in the...
Hsa_circ_0007590/PTBP1 complex reprograms glucose metabolism by reducing the stability of...
Nature· 18 hours agoThe role of circular RNAs (circRNAs) in glucose metabolism in pancreatic duct adenocarcinoma (PDAC) remains elusive. Through RNA sequencing of cells cultured under conditions ...
Biotechs Zero in on New Pancreatic Therapies as Global Pancreatic Cancer Market Expected Reach to...
Morningstar· 4 days agoFN Media Group News Commentary - The pancreatic cancer market encompasses the pharmaceutical and healthcare sectors dedicated to addressing the prevention ...
...Clinical Trial Evaluating Motixafortide in First-Line Pancreatic Cancer (PDAC) at American...
FOX 23 News Albany· 4 days agoThe CheMo4METPANC trial is evaluating the company's CXCR4 inhibitor motixafortide, the PD-1...
ASCO 2024: Verastem’s combo therapy for pancreatic cancer hits early trial success
Clinical Trials Arena via Yahoo Finance· 4 days agoThe US biopharma company announced the initial interim safety and efficacy results as it gears up...
BioLineRx reports positive pancreatic cancer trial results By Investing.com
Investing.com· 3 days agoBioLineRx Ltd. (NASDAQ: BLRX), a biopharmaceutical company, announced encouraging results from the...
Oncolytics Biotech® ASCO Abstracts Highlight Pelareorep's Potential in Pancreatic Cancer and...
FOX 23 News Albany· 4 days agoOne is a trial-in-progress abstract discussing cohort 5 of the GOBLET study, which will evaluate the combination of pelareorep and modified FOLFIRINOX (mFOLFIRINOX) with and without atezolizumab ...
Verastem (VSTM) Up on Upbeat Early Pancreatic Cancer Study Data
Zacks via Yahoo Finance· 3 days agoVerastem (VSTM) gains 57% post-market on achieving a confirmed partial response in 83% of first-line...
Alligator Bioscience To Present Positive Phase 2 Mitazalimab Data in Pancreatic Cancer at 2024 ASCO...
Morningstar· 4 days agoOPTIMIZE-1 study results showed confirmed ORR of 40.4%, unconfirmed ORR of 50.9% and DCR of 79% in 57 evaluable patients with chemotherapy-naïve mPDACThe encouraging duration ...
Inhibition of lysosomal TRPML1 channel eliminates breast cancer stem cells by triggering ferroptosis...
Nature· 18 hours agoPharmacological inhibition and genetic depletion of TRPML1 promote ferroptosis in breast CSCs, reduce their stemness, and enhance the sensitivity of breast cancer cells to ...
Ad
related to: pancreatic cancer chemotherapy